Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENIOLISIB vs LETERMOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENIOLISIB vs LETERMOVIR: Safety Overview

Metric LENIOLISIB LETERMOVIR
Total FAERS Reports 570 1,416
Deaths Reported 6 252
Death Rate 1.1% 17.8%
Hospitalizations 54 398
Average Patient Age 19.4 yrs 46.6 yrs
% Female Patients 27.3% 42.7%
FDA Approval Date Mar 24, 2023 Aug 30, 2024
Manufacturer Pharming Healthcare Inc. Merck Sharp & Dohme LLC
Route ORAL ORAL
Marketing Status Prescription Prescription